Leukemia News and Research

RSS
Leukemia (Leukaemia) is a cancer of the blood cells. It is the most common type of blood cancer and affects 10 times as many adults as children. Most people diagnosed with leukemia are over 50 years old. No one knows why some people develop leukemia and others do not. However, scientists have identified some risk factors for the disease. Most people who have known risk factors do not get leukemia, while many who do get the disease have none of these risk factors. During the early stages of leukemia, there may be no symptoms. Many of the symptoms of leukemia don't become apparent until a large number of normal blood cells are crowded out by leukemia cells.
Caregivers of cancer patients face high rates of PTSD

Caregivers of cancer patients face high rates of PTSD

In the Thymus We Trust: ProTcell Therapy & the Future of Allogeneic Immunotherapy

In the Thymus We Trust: ProTcell Therapy & the Future of Allogeneic Immunotherapy

Congenital heart defects may be linked to increased cancer risk in babies and mothers

Congenital heart defects may be linked to increased cancer risk in babies and mothers

Study highlights the role of ELF4 as a key transcription factor in development, immunity, and oncology

Study highlights the role of ELF4 as a key transcription factor in development, immunity, and oncology

New test could predict life-threatening side effects of cancer immunotherapy

New test could predict life-threatening side effects of cancer immunotherapy

New supercharged CAR-T cell therapy shows promise against resistant cancers

New supercharged CAR-T cell therapy shows promise against resistant cancers

GLP-1 drugs may cut risk of leukemia and lymphoma in type 2 diabetes patients

GLP-1 drugs may cut risk of leukemia and lymphoma in type 2 diabetes patients

Anti-malarial drug pyronaridine could be repurposed to treat cancer

Anti-malarial drug pyronaridine could be repurposed to treat cancer

Study identifies key role of JMJD1C in acute myeloid leukemia

Study identifies key role of JMJD1C in acute myeloid leukemia

Stress granules as potential biomarkers for neurodegenerative diseases

Stress granules as potential biomarkers for neurodegenerative diseases

Future of cancer coverage for women federal firefighters uncertain under Trump

Future of cancer coverage for women federal firefighters uncertain under Trump

UCSF study reveals lungs as source of hematopoietic stem cells

UCSF study reveals lungs as source of hematopoietic stem cells

Advancements in molecular diagnostics for hematopoietic and lymphocytic neoplasms

Advancements in molecular diagnostics for hematopoietic and lymphocytic neoplasms

Innovative combination of treatments effectively kills acute myeloid leukemia cells

Innovative combination of treatments effectively kills acute myeloid leukemia cells

PFAS exposure via drinking water contamination may play a role in childhood cancer risk

PFAS exposure via drinking water contamination may play a role in childhood cancer risk

New research reveals how cell state affects leukemia progression

New research reveals how cell state affects leukemia progression

Development of lymphoma following CAR-T cell therapy

Development of lymphoma following CAR-T cell therapy

CPRIT awards nearly $23 million to MD Anderson for cancer research projects

CPRIT awards nearly $23 million to MD Anderson for cancer research projects

WHO initiative provides free cancer drugs to African children

WHO initiative provides free cancer drugs to African children

Cancer-free for 18 years: CAR-T therapy sets new milestone in neuroblastoma treatment

Cancer-free for 18 years: CAR-T therapy sets new milestone in neuroblastoma treatment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.